Madhukar Pai | |
---|---|
Born |
Vellore, India |
Alma mater | |
Known for | Tuberculosis and public health research, equity advocacy |
Awards |
|
Madhukar Pai (also known as Madhu Pai) is an Indian medical doctor, academic, advocate, [1] writer, [2] and university professor. Pai's work is around global health, specifically advocacy for better treatment for tuberculosis [3] with a focus on South Africa and India. [4] [5] Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health [6] and holds a Canada Research Chair in Epidemiology and Global Health at McGill University. [7]
Pai completed medical training and his community medicine residency at the Christian Medical College [8] Vellore, India. [4] He received his Ph.D in epidemiology from University of California, Berkeley. [4] He also did a postdoctoral fellowship at the University of California San Francisco. [4]
Pai serves on the Scientific Advisory Committee of FIND (the global alliance for diagnostics) [4] and is on the World Health Organization's Strategic Advisory Group of Experts on In Vitro Diagnostics and the Access Advisory Committee of TB Alliance. [4] He is the Chair of the Public-Private Mix Working Group of the Stop TB Partnership. [4] Pai is also on the editorial boards of BMJ Global Health, PLoS Medicine, Lancet Infectious Diseases, [4] and is an Editor-in-Chief of PLOS Global Public Health. [9]
Pai is a frequent media commentator on the COVID-19 pandemic in India, [10] [2] [11] and in 2021 drew comparisons of the collective global action taken in response to the COVID19 pandemic versus the relative inaction towards tuberculosis. [12] His 2021 paper in PLOS Medicine addressed power asymmetries in global health. [13]
In 2020 [14] and in 2021 [15] he published papers and contributions about the decolonisation of global health work.
In 2021, Pai was critical of the global failure to widely vaccinate people against COVID-19, accused high-income nations of vaccine hoarding, and called for a waiver of intellectual property laws regarding COVID19 vaccines. [16] In 2022 he described the global response to COVID-19 as an "unmitigated disaster". [17]
Madhukar Pai | |
---|---|
Born |
Vellore, India |
Alma mater | |
Known for | Tuberculosis and public health research, equity advocacy |
Awards |
|
Madhukar Pai (also known as Madhu Pai) is an Indian medical doctor, academic, advocate, [1] writer, [2] and university professor. Pai's work is around global health, specifically advocacy for better treatment for tuberculosis [3] with a focus on South Africa and India. [4] [5] Pai is the inaugural Chair of the Department of Global and Public Health in the School of Population and Global Health [6] and holds a Canada Research Chair in Epidemiology and Global Health at McGill University. [7]
Pai completed medical training and his community medicine residency at the Christian Medical College [8] Vellore, India. [4] He received his Ph.D in epidemiology from University of California, Berkeley. [4] He also did a postdoctoral fellowship at the University of California San Francisco. [4]
Pai serves on the Scientific Advisory Committee of FIND (the global alliance for diagnostics) [4] and is on the World Health Organization's Strategic Advisory Group of Experts on In Vitro Diagnostics and the Access Advisory Committee of TB Alliance. [4] He is the Chair of the Public-Private Mix Working Group of the Stop TB Partnership. [4] Pai is also on the editorial boards of BMJ Global Health, PLoS Medicine, Lancet Infectious Diseases, [4] and is an Editor-in-Chief of PLOS Global Public Health. [9]
Pai is a frequent media commentator on the COVID-19 pandemic in India, [10] [2] [11] and in 2021 drew comparisons of the collective global action taken in response to the COVID19 pandemic versus the relative inaction towards tuberculosis. [12] His 2021 paper in PLOS Medicine addressed power asymmetries in global health. [13]
In 2020 [14] and in 2021 [15] he published papers and contributions about the decolonisation of global health work.
In 2021, Pai was critical of the global failure to widely vaccinate people against COVID-19, accused high-income nations of vaccine hoarding, and called for a waiver of intellectual property laws regarding COVID19 vaccines. [16] In 2022 he described the global response to COVID-19 as an "unmitigated disaster". [17]